Respiratory Virus Detection Kit

Accuracy and Speed in Respiratory Virus Detection

The Neumo ViralDx Kit heralds a transformative, groundbreaking era for detecting genomic RNA of key respiratory viruses: SARS-CoV-2, Influenza A & B, and Respiratory Syncytial Virus (RSV). Its pioneering, avant-garde feature resides in its unmatched capability to seamlessly integrate reverse transcription (RT) and real-time PCR (qPCR) detection of target genes into a singular, efficient RT-qPCR procedure. The ramifications of such an unparalleled mechanism? A refined, streamlined laboratory process allowing virology and molecular biology specialists to promptly attain definitive, trustable results with record-breaking speed.

Distinguishing the Neumo ViralDx Kit is its ingenious, fail-proof endogenous positive control. This masterfully crafted control flawlessly detects the RNase P gene, serving dual, essential purposes: guaranteeing the uninterrupted, optimal performance of the RT-qPCR system and significantly easing the interpretation process amidst intricate qualitative analysis.

In an evolving scientific environment where adherence to quality is non-negotiable, the Neumo ViralDx Kit emerges triumphant. Every component rigorously adheres to the most demanding, rigorous standards of molecular diagnostics. Such a pronounced level of quality assurance testifies to the kit’s stellar manufacturing precision, solidifying trust in the materials and methodologies applied.

Key Features of the Superior Neumo ViralDx Kit

Unified RT-qPCR Prowess: This superior kit cuts down on manual intervention and resource consumption by reliably processing multiple targets in a singular, impeccable RT-qPCR cycle.
Expansive Analysis Compatibility: Impressively harmonizes with a broad array of respiratory virus-related products, enabling a comprehensive, unified analysis.

Premium Quality Compliance: With a steadfast adherence to the loftiest molecular diagnostic standards, the kit delivers unparalleled quality assurance.
Endogenous Positive Control: The indispensable built-in RNase P gene control optimizes the RT-qPCR system’s functionality and is pivotal in nuanced qualitative interpretation.

Tailored, Sophisticated Design: Precisely and diligently crafted for in vitro diagnostic use, focusing its unequaled specificity and accuracy on detecting respiratory viruses.

The Future of Respiratory Diagnostics: Elevating Laboratory Standards with Neumo ViralDx

Wrapping up, the Neumo ViralDx Test Kit symbolizes a monumental stride in the world of respiratory virus detection. With its singular ability to precisely pinpoint genomic RNA, refine lab processes, and maintain the highest quality thresholds, it stands out as an authentic trailblazer. Committed to precision, agility, and reliability, it not only demystifies intricate evaluations but also lays down the blueprint for future innovations in contemporary labs. The Neumo ViralDx Kit isn’t merely a diagnostic instrument; it’s the torchbearer of evolution, heralding a new dawn in medical diagnostics.

The kit is equipped with reagents for 96 reactions, including:

• Neumo Master Mix: contains the oligonucleotides and hydrolysis probes to perform
  system-specific amplification of SARS-CoV-2 (FAM), influenza (VIC), RSV (Cy5) and
  human endogenous control, RNase P (Texas Red).
• RT-PCR Master Mix: PCR Master Mix with the nucleotides, MgCl2, real-time PCR enzyme
  and buffer required to perform real-time PCR.
• RTase: retrotranscriptase enzyme to carry out the reverse transcription of RNA
  to complementary DNA (cDNA).
• Positive Control: positive control with the target sequences for the amplification
  of the SARS-CoV-2, influenza, RSV and RNase P endogenous control targets.